This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
5hi3
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
==Binding site elucidation and structure guided design of macrocyclic IL-17A antagonists== | ==Binding site elucidation and structure guided design of macrocyclic IL-17A antagonists== | ||
| - | <StructureSection load='5hi3' size='340' side='right' caption='[[5hi3]], [[Resolution|resolution]] 2.15Å' scene=''> | + | <StructureSection load='5hi3' size='340' side='right'caption='[[5hi3]], [[Resolution|resolution]] 2.15Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[5hi3]] is a 7 chain structure with sequence from [ | + | <table><tr><td colspan='2'>[[5hi3]] is a 7 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] and [https://en.wikipedia.org/wiki/Synthetic_construct Synthetic construct]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5HI3 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5HI3 FirstGlance]. <br> |
| - | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=63O:N-(4-{2-[({1-[2-(DIMETHYLAMINO)-2-OXOETHYL]CYCLOPENTYL}ACETYL)AMINO]ETHYL}PHENYL)-2-FLUORO-NALPHA-[(1-METHYL-1H-PYRAZOL-5-YL)CARBONYL]-L-PHENYLALANINAMIDE'>63O</scene> | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.15Å</td></tr> |
| - | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=63O:N-(4-{2-[({1-[2-(DIMETHYLAMINO)-2-OXOETHYL]CYCLOPENTYL}ACETYL)AMINO]ETHYL}PHENYL)-2-FLUORO-NALPHA-[(1-METHYL-1H-PYRAZOL-5-YL)CARBONYL]-L-PHENYLALANINAMIDE'>63O</scene>, <scene name='pdbligand=ACE:ACETYL+GROUP'>ACE</scene></td></tr> | |
| - | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5hi3 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5hi3 OCA], [https://pdbe.org/5hi3 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5hi3 RCSB], [https://www.ebi.ac.uk/pdbsum/5hi3 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5hi3 ProSAT]</span></td></tr> | |
| - | + | ||
| - | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | |
</table> | </table> | ||
== Function == | == Function == | ||
| - | [ | + | [https://www.uniprot.org/uniprot/IL17_HUMAN IL17_HUMAN] Induces stromal cells to produce proinflammatory and hematopoietic cytokines. Enhances the surface expression of ICAM1/intracellular adhesion molecule 1 in fibroblasts. |
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
| Line 21: | Line 19: | ||
</div> | </div> | ||
<div class="pdbe-citations 5hi3" style="background-color:#fffaf0;"></div> | <div class="pdbe-citations 5hi3" style="background-color:#fffaf0;"></div> | ||
| + | |||
| + | ==See Also== | ||
| + | *[[Interleukin 3D structures|Interleukin 3D structures]] | ||
== References == | == References == | ||
<references/> | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
| - | [[Category: | + | [[Category: Homo sapiens]] |
| - | [[Category: | + | [[Category: Large Structures]] |
| - | [[Category: | + | [[Category: Synthetic construct]] |
| - | [[Category: | + | [[Category: Liu S]] |
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
Current revision
Binding site elucidation and structure guided design of macrocyclic IL-17A antagonists
| |||||||||||
